Real-World Effectiveness of IHATTM in Women with Iron Deficiency Across Pregnancy, Postpartum and Abnormal Uterine Bleeding
Nutrients · 27.07.2026 · 18 (15) · 2446
DOI: 10.3390/nu18152446 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Nutrients, online erschienen am 27.07.2026. Verfasst von Gabriele Saccone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Reproductive Science and Dentistry, School of Medicine, University of Naples Federico II, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Uterine Hemorrhage, Ferric Compounds. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Enteralia Bioscience S.r.l., Nemysis Ltd..
Abstract (Originalsprache)
Objective
To evaluate the real-world effectiveness and tolerability of Iron Hydroxide Adipate Tartrate (IHATTM) in women with iron deficiency across three common obstetric and gynecologic clinical settings: pregnancy, the postpartum period, and abnormal uterine bleeding.
Methods
This prospective multicenter observational real-world study included women with iron deficiency managed in routine clinical practice across Italy. Participating gynecologists collected data using standardized case report forms. Patients received IHATTM according to routine clinical practice and were followed for approximately three months. Baseline demographic and hematologic parameters were recorded, including hemoglobin and ferritin levels. The primary outcome was the change in hemoglobin between baseline and follow-up. Secondary outcomes included changes in ferritin levels, treatment adherence, and tolerability.
Results
A total of 517 women was included in the analysis. The study population included pregnant women (N = 287, 55.5%), women with abnormal uterine bleeding (N = 161, 31.1%), and women in the postpartum period (N = 69, 13.3%). Improvements in hemoglobin were observed across all clinical settings, with hemoglobin increasing from 10.35 g/dL at baseline to 11.63 g/dL at three months, corresponding to a mean increase of 1.28 g/dL. Mean ferritin levels increased from 22.50 ng/mL to 37.74 ng/mL in three months. Treatment adherence was high or moderate in 93.4% of patients. Gastrointestinal adverse events were infrequent, with constipation (9.7%) and nausea (4.8%) among the most reported.
Conclusions
In this prospective real-world multicenter study, treatment with IHATTM was associated with meaningful improvements in hemoglobin and iron stores in women with iron deficiency across pregnancy, postpartum, and abnormal uterine bleeding. The treatment showed good adherence and a favorable tolerability profile in routine clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Reproductive Science and Dentistry, School of Medicine, University of Naples Federico II, 80131 Naples, Italy.
- Department of Obstetrics and Gynecology, IRCCS San Raffaele Scientific Institute, University Vita and Salute, 20132 Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, 20072 Milan, Italy.
ORCID-Profile: Mariarosaria Motta, Francesco De Seta, Salvatore Mola, Sara Iannantuoni, Nicoletta Di Simone
Förderung
- Enteralia Bioscience S.r.l.
- Nemysis Ltd.
Zitieren
APA
Saccone, G., Motta, M., De Seta, F., Mola, S., Iannantuoni, S., & Di Simone, N. (2026). Real-World Effectiveness of IHATTM in Women with Iron Deficiency Across Pregnancy, Postpartum and Abnormal Uterine Bleeding. Nutrients, 18(15), 2446. https://doi.org/10.3390/nu18152446
Vancouver
Saccone G, Motta M, De Seta F, Mola S, Iannantuoni S, Di Simone N. Real-World Effectiveness of IHATTM in Women with Iron Deficiency Across Pregnancy, Postpartum and Abnormal Uterine Bleeding. Nutrients. 2026;18(15):2446. doi:10.3390/nu18152446
BibTeX
@article{Saccone2026,
author = {Saccone, Gabriele and Motta, Mariarosaria and De Seta, Francesco and Mola, Salvatore and Iannantuoni, Sara and Di Simone, Nicoletta},
title = {Real-World Effectiveness of IHATTM in Women with Iron Deficiency Across Pregnancy, Postpartum and Abnormal Uterine Bleeding},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {15},
pages = {2446},
doi = {10.3390/nu18152446}
}
EUVIMED